Crypto exchange Gemini lifted the price range for its initial public offering to $24 to $26 per share, setting up a debut that could value the company at about $3.2 billion, according to a filing this week.
The New York-based exchange, run by Cameron and Tyler Winklevoss, previously aimed for a range of $17 to $19. The share count remains unchanged at 16.7 million.
At the top end, Gemini would raise roughly $435 million, up from about $317 million under its earlier goal.
Nasdaq partnership
Nasdaq has agreed to invest $50 million in the IPO, highlighting institutional backing for the crypto exchange as it prepares to go public under the ticker GEMI.
The partnership is seen as a vote of confidence in Gemini’s long-term prospects and a signal of Wall Street’s growing acceptance of digital asset platforms.
The IPO comes amid a flurry of fintech listings and renewed appetite for digital-asset companies. However, investor enthusiasm will hinge on Gemini’s ability to stabilize its finances while navigating an evolving regulatory environment.
Enrollment Closing Soon…
Secure your spot in the 5-day Crypto Investor Blueprint before it disappears. Learn the strategies that separate winners from bagholders.
Brought to you by CryptoSlate
CFTC nominee allegations
The IPO is also taking place against the backdrop of fresh regulatory controversy after President Donald Trump’s CFTC chair nominee Brian Quintenz alleged that Tyler Winklevoss attempted to sway his confirmation after failing to initiate a review of Gemini’s long-running dispute with the agency.
Quintenz released private text messages showing Winklevoss sharing Gemini’s complaint against the CFTC Inspector General, which accused the regulator of pursuing unfair enforcement actions.
Quintenz said he refused to promise favorable treatment, committing only to address the matter “fully and fairly” if confirmed. In the messages, Winklevoss expressed frustration over what he described as years of selective enforcement and urged Quintenz to align with Trump’s push to reform regulatory oversight.
The disclosure, made just days before Gemini’s market debut, highlights the company’s high stakes as it seeks to convince investors and regulators of its stability.
